BWAY

Brainsway
BWAY

15.89 USD
+0.01
0.06%
At close Updated May 29, 4:00 PM EDT
1 day
0.06%
5 days
4.54%
1 month
0.06%
3 months
34.09%
6 months
87.16%
Year to date
64.66%
1 year
204.41%
5 years
188.91%
10 years
186.31%
 

About: BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Employees: 129

Healthcare Medical Devices
0
Funds holding %
of 8,059 funds
Explore Fund Trends
0
Analysts bullish %
of 1 analysts
See Analyst Outlook
0
Positive news %
of 5 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™